Patient-reported measures of well-being in older multiple myeloma patients: use of secondary data source

Background Changes in well-being of patients with multiple myeloma (MM) before and after diagnosis have not been quantified. Aims Explore the use of secondary data to examine the changes in the well-being of older patients with MM. Methods We used the Health and Retirement Study (HRS), linked to Med...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aging clinical and experimental research 2020-06, Vol.32 (6), p.1153-1160
Hauptverfasser: Cenzer, Irena, Berger, Karin, Rodriguez, Annette M., Ostermann, Helmut, Covinsky, Kenneth E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Changes in well-being of patients with multiple myeloma (MM) before and after diagnosis have not been quantified. Aims Explore the use of secondary data to examine the changes in the well-being of older patients with MM. Methods We used the Health and Retirement Study (HRS), linked to Medicare claims to identify older MM patients. We compared patient-reported measures (PRM), including physical impairment, sensory impairment, and patient experience (significant pain, self-rated health, depression) in the interviews before and after MM diagnosis using McNemar’s test. We propensity-matched each MM patient to five HRS participants without MM diagnosis based on baseline characteristics. We compared the change in PRM between the MM patients and their matches. Results We identified 92 HRS patients with MM diagnosis (mean age = 74.6, SD = 8.4). Among the surviving patients, there was a decline in well-being across most measures, including ADL difficulty (23% to 40%, p value = 0.016), poor or fair self-rated health (38% to 61%, p value = 0.004), and depression (15% to 30%, p value = 0.021). Surviving patients reported worse health than participants without MM across most measures, including ADL difficulty (40% vs. 27%, p value = 0.04), significant pain (38% vs. 22%, p value = 0.01), and depression (29% vs. 11%, p value = 0.003). Discussion Secondary data were used to identify patients with MM diagnosis, and examine changes across multiple measures of well-being. MM diagnosis negatively affects several aspects of patients’ well-being, and these declines are larger than those experienced by similar participants without MM. Conclusion The results of this study are valuable addition to understanding the experience of patients with MM, despite several data limitations.
ISSN:1720-8319
1594-0667
1720-8319
DOI:10.1007/s40520-019-01465-3